A. Jobke

714 total citations
29 papers, 311 citations indexed

About

A. Jobke is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pathology and Forensic Medicine. According to data from OpenAlex, A. Jobke has authored 29 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Hematology, 7 papers in Public Health, Environmental and Occupational Health and 6 papers in Pathology and Forensic Medicine. Recurrent topics in A. Jobke's work include Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). A. Jobke is often cited by papers focused on Acute Lymphoblastic Leukemia research (7 papers), Acute Myeloid Leukemia Research (5 papers) and Lymphoma Diagnosis and Treatment (4 papers). A. Jobke collaborates with scholars based in Germany, Switzerland and Austria. A. Jobke's co-authors include Bernhard A. Peskar, B. M. Peskar, G. Hertting, P. Weinel, B. Stollmann, J. Treuner, R. Ludwig, H. Riehm, G. Schellong and St. Müller-Weihrich and has published in prestigious journals such as FEBS Letters, Human Genetics and Naunyn-Schmiedeberg s Archives of Pharmacology.

In The Last Decade

A. Jobke

29 papers receiving 298 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Jobke Germany 11 78 73 71 63 51 29 311
Salvador Bruno United States 11 18 0.2× 48 0.7× 102 1.4× 70 1.1× 63 1.2× 23 472
Richard A. Lutes United States 7 23 0.3× 62 0.8× 80 1.1× 25 0.4× 68 1.3× 8 346
Orren Beaty United States 8 41 0.5× 148 2.0× 92 1.3× 7 0.1× 71 1.4× 11 373
Amalia A. van Everdingen Netherlands 10 25 0.3× 11 0.2× 59 0.8× 20 0.3× 54 1.1× 10 615
Sara Lewis United Kingdom 8 29 0.4× 30 0.4× 40 0.6× 41 0.7× 45 0.9× 12 318
Kuniaki Meguro Japan 14 34 0.4× 34 0.5× 152 2.1× 20 0.3× 337 6.6× 29 602
Debra M. Prow United States 9 13 0.2× 47 0.6× 29 0.4× 15 0.2× 41 0.8× 13 265
I Sato Japan 10 12 0.2× 25 0.3× 27 0.4× 14 0.2× 67 1.3× 20 434
Shunji Hashizume Japan 5 22 0.3× 55 0.8× 170 2.4× 9 0.1× 85 1.7× 9 461
D. Gordon United Kingdom 5 53 0.7× 32 0.4× 11 0.2× 10 0.2× 39 0.8× 7 333

Countries citing papers authored by A. Jobke

Since Specialization
Citations

This map shows the geographic impact of A. Jobke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Jobke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Jobke more than expected).

Fields of papers citing papers by A. Jobke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Jobke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Jobke. The network helps show where A. Jobke may publish in the future.

Co-authorship network of co-authors of A. Jobke

This figure shows the co-authorship network connecting the top 25 collaborators of A. Jobke. A scholar is included among the top collaborators of A. Jobke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Jobke. A. Jobke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Niemeyer, C., Guido Trenn, A. Jobke, et al.. (2015). Treatment Trial with Recombinant Human Erythropoietin in Children with Congenital Hypoplastic Anemia. Contributions to nephrology. 88. 276–281. 1 indexed citations
2.
Graf, Norbert, et al.. (1990). Malignome in Familien mit krebskranken Kindern*. Klinische Pädiatrie. 202(4). 282–287. 1 indexed citations
3.
Bielack, Stefan, Jörn D. Beck, G. Delling, et al.. (1989). Neoadjuvante Chemotherapie des Osteosarkoms. Klinische Pädiatrie. 201(4). 275–284. 10 indexed citations
4.
Lampert, F., Jochen Harbott, J. Ritterbach, et al.. (1988). T-cell acute childhood lymphoblastic leukemia with chromosome 14q11 anomaly: a morphologic, immunologic, and cytogenetic analysis of 10 patients. Annals of Hematology. 56(3). 117–123. 21 indexed citations
5.
Jürgens, Heribert, Jürgen Dunst, D. Harms, et al.. (1988). Die GPO cooperativen Ewing-Sarkom Studien CESS 81/86:. Klinische Pädiatrie. 200(3). 243–252. 39 indexed citations
6.
Göz, Gernot, et al.. (1988). Die kraniofaziale Entwicklung nach Strahlentherapie im Kindesalter. Journal of Orofacial Orthopedics / Fortschritte der Kieferorthopädie. 49(1). 29–36. 4 indexed citations
7.
Jobke, A., et al.. (1985). [Persistent Epstein-Barr virus infection].. PubMed. 133(12). 897–900. 3 indexed citations
8.
Müller-Weihrich, St., Jörn D. Beck, G. Henze, et al.. (1984). BFM-Studie 1981/83 zur Behandlung hochmaligner Non-Hodgkin-Lymphome bei Kindern: Ergebnisse einer nach histologisch-immunologischem Typ und Ausbreitungsstadium stratefizierten Therapie. Klinische Pädiatrie. 196(3). 135–142. 20 indexed citations
9.
Creutzig, Ursula, et al.. (1984). Akute myeloische Leukämie bei Kindern unter 2 Jahren: Untersuchungen und Behandlungsergebnisse bei 23 Kindern der AML-Therapiestudie BFM-78*, **. Klinische Pädiatrie. 196(3). 130–134. 7 indexed citations
10.
Creutzig, Ursula, G. Schellong, J. Ritter, et al.. (1983). Improved Results in Treatment of Acute Myelogenous Leukemia in Children — Report of the German Cooperative AML Study BFM-78. Hämatologie und Bluttransfusion. 28. 46–50. 3 indexed citations
11.
Breu, H., I. Grosch-Wörner, A. Jobke, et al.. (1982). Abgestufte Chemotherapie und reduzierte Strahlendosis beim Morbus Hodgkin im Kindesalter - Ein Bericht über 170 Patienten der kooperativen Therapiestudie HD 78. Klinische Pädiatrie. 194(4). 233–241. 11 indexed citations
12.
Göz, Gernot, et al.. (1982). [Craniofacial growth after radiotherapy in children (combination therapy of ALL) (author's transl)].. PubMed. 158(4). 238–41. 1 indexed citations
13.
Müller-Weihrich, St., G. Henze, A. Jobke, et al.. (1982). BFM-Studie 1975/81 zur Behandlung der Non-Hodgkin-Lymphome hoher Malignität bei Kindern und Jugendlichen*. Klinische Pädiatrie. 194(4). 219–225. 16 indexed citations
14.
Wolff, G., et al.. (1980). Linkage of genes for chronic granulomatous disease and Xg. Human Genetics. 54(2). 269–271. 13 indexed citations
15.
Lesch, R, H. W. Goedde, I. Witt, et al.. (1978). Hepatopathie bei homozygotem α1-Antitrypsin-Mangel. DMW - Deutsche Medizinische Wochenschrift. 103(4). 161–166. 4 indexed citations
16.
Meyer, Dieter, et al.. (1976). Conversion of angiotensin I in isolated perfused guinea-pig and rat lung. Naunyn-Schmiedeberg s Archives of Pharmacology. 292(2). 183–187. 2 indexed citations
17.
Jobke, A., Bernhard A. Peskar, & G. Hertting. (1976). On the relation between release of prostaglandins and contractility of rabbit splenic capsular strips. Naunyn-Schmiedeberg s Archives of Pharmacology. 292(1). 35–42. 14 indexed citations
18.
Jobke, A. & G. Hertting. (1974). Proceedings: Interactions between prostaglandin release and contractile state of isolated splenic strips.. PubMed. 282(Suppl). suppl 282:R41–suppl 282:R41. 1 indexed citations
19.
Hahn, F., et al.. (1973). Changes in Guinea-Pig Liver Heparin and Histamine during Anaphylaxis. International Archives of Allergy and Immunology. 44(5). 717–734. 3 indexed citations
20.
Jobke, A., Bernhard A. Peskar, & B. M. Peskar. (1973). On the specificity of antisera against prostaglandins A2 and E2. FEBS Letters. 37(2). 192–196. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Salvador Bruno Breakdown of academic impact, for papers by Richard A. Lutes Breakdown of academic impact, for papers by Orren Beaty Breakdown of academic impact, for papers by Amalia A. van Everdingen Breakdown of academic impact, for papers by Sara Lewis Breakdown of academic impact, for papers by Kuniaki Meguro Breakdown of academic impact, for papers by Debra M. Prow Breakdown of academic impact, for papers by I Sato Breakdown of academic impact, for papers by Shunji Hashizume Breakdown of academic impact, for papers by D. Gordon
Rankless by CCL
2026